1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Agranulocytosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberton, M; Bussolino, F; Caligaris Cappio, F; Camussi, G; Coda, R; Macchiorlatti, E; Roffinello, C; Segoloni, G; Tetta, C | 1 |
| Bussolino, F; Camussi, G; Tetta, C | 1 |
| Bussolino, F; Camussi, G; Chiara Deregibus, M; Segoloni, G; Tetta, C | 1 |
| Barnes, PJ; Chung, KF; Kioumis, I; Lammers, JW; McCusker, M; Nichol, GM | 1 |
| Issekutz, AC; Ripley, M; Rochon, Y | 1 |
| Mata, R; Muniain, MA; Pérez, JJ; Pozuelo, F; Rodríguez, MC; Rodríguez, MD; Romero, A | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Agranulocytosis
| Article | Year |
|---|---|
Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man.
Topics: Administration, Inhalation; Adult; Agranulocytosis; Blood Pressure; Bronchial Spasm; Epoprostenol; Forced Expiratory Flow Rates; Heart Rate; Humans; Infusions, Intravenous; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Random Allocation | 1990 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Agranulocytosis
| Article | Year |
|---|---|
Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.
Topics: Agranulocytosis; Animals; Antigen-Antibody Complex; Cell Aggregation; Epoprostenol; Neutropenia; Neutrophils; Platelet Activating Factor; Prostaglandins; Rabbits; Thrombocytopenia | 1983 |
Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit.
Topics: Agranulocytosis; Animals; Epoprostenol; Female; Kinetics; Male; Neutropenia; Platelet Activating Factor; Prostaglandins; Rabbits | 1983 |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
Topics: Agranulocytosis; Animals; Cell Aggregation; Epoprostenol; Humans; In Vitro Techniques; Lysophosphatidylcholines; Neutropenia; Neutrophils; Platelet Activating Factor; Prostaglandins; Rabbits | 1981 |
Synergistic inhibition of complement induced granulocyte margination by BW755C and calcium channel blockers.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Agranulocytosis; Animals; Calcium; Calcium Channel Blockers; Cell Aggregation; Chemotactic Factors; Complement System Proteins; Female; Granulocytes; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pyrazoles; Rabbits; Verapamil | 1985 |
[Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
Topics: Agranulocytosis; Animals; Cell Aggregation; Complement System Proteins; Furans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neutropenia; Platelet Activating Factor; Quinacrine; Rabbits; Zymosan | 1988 |